Ignite Creation Date:
2024-05-06 @ 6:25 PM
Last Modification Date:
2024-10-26 @ 2:47 PM
Study NCT ID:
NCT05650918
Status:
COMPLETED
Last Update Posted:
2023-10-12
First Post:
2022-08-08
Brief Title:
MesoPherMitazalimab-combination Therapy in Metastatic Pancreatic Disease REACtiVe-2 Trial
Sponsor:
Joachim Aerts MD PhD
Organization:
Erasmus Medical Center
Organization Data
Organization:
Erasmus Medical Center
Class:
OTHER
Study ID:
NL7659200021
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Joachim Aerts MD PhD
Lead Sponsor Class:
OTHER
Responsible Party:
Joachim Aerts MD PhD
Responsible Party Title:
Prof dr
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Erasmus Medical Center
Old Name:
None
Old Organization:
None